Evidence map›Paper›PMID 40334287›Full record

ArticleJournal of medical Internet research2025

Improving Recruitment Through Social Media and Web-Based Advertising to Evaluate the Genetic Risk and Long-Term Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Community-Based Survey.

Elizabeth A Williams, Michelle D Martin-Pozo, Alexis H Yu, Krystyna Daniels, Madeline Marks, April O'Connor, Elizabeth J Phillips

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elizabeth A WilliamsCenter for Drug Safety and Immunology, Vanderbilt University Medical Center, 2611 West End Avenue, STE 210, Nashville, TN, United States, 1 615-322-9174.ORCID 0009-0000-3648-4033
Michelle D Martin-PozoCenter for Drug Safety and Immunology, Vanderbilt University Medical Center, 2611 West End Avenue, STE 210, Nashville, TN, United States, 1 615-322-9174.ORCID 0000-0002-1526-9569
Alexis H YuCenter for Drug Safety and Immunology, Vanderbilt University Medical Center, 2611 West End Avenue, STE 210, Nashville, TN, United States, 1 615-322-9174.ORCID 0009-0003-0775-493X
Krystyna DanielsDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID 0009-0006-4400-7118
Madeline MarksCenter for Drug Safety and Immunology, Vanderbilt University Medical Center, 2611 West End Avenue, STE 210, Nashville, TN, United States, 1 615-322-9174.ORCID 0009-0000-0923-4872
April O'ConnorCenter for Drug Safety and Immunology, Vanderbilt University Medical Center, 2611 West End Avenue, STE 210, Nashville, TN, United States, 1 615-322-9174.ORCID 0009-0005-8830-8898
Elizabeth J PhillipsCenter for Drug Safety and Immunology, Vanderbilt University Medical Center, 2611 West End Avenue, STE 210, Nashville, TN, United States, 1 615-322-9174.ORCID 0000-0002-7623-3383

Funding

Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivorsR01HG010863 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH · 2019 to 2022
$3.1M
Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) 2023R13AR082704 · NIAMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH · 2023 to 2023
$45k
NHGRI NIH HHS R01 HG010863NIAMS NIH HHS R13 AR082704
6 · The paper itself

Abstract

Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are genetically mediated, life-threatening reactions usually caused by a medication in adults. These genetic associations promise an opportunity for pre-prescription screening, prevention, and understanding influences at a population level. Importantly, older adults disproportionally face more severe SJS/TEN reactions and higher mortality rates. However, the study of genetic risk and long-term sequelae of SJS/TEN across racially diverse populations and age groups is hampered by many factors, including rarity, social disparities, and trust in health care and providers, impacting access to hospital- and clinic-based research studies. Objective: This paper aims to explore the utility of multiple social media and web-based search tools to increase study enrollment numbers, diversity, and inclusivity of all populations and ages in the SJS Survivor Study. Methods: The community-based SJS/TEN Survivor Study remotely recruited drug-induced SJS/TEN survivors in the United States. The aims were to help determine genetic risk and long-term outcomes of SJS/TEN. Baseline recruitment included advertisements through the SJS Foundation website and American Burn Association newsletter. Two years into the study, in hopes of improving accessibility and enrollment diversity, social media ads were introduced on the Vanderbilt University Medical Center (VUMC) Facebook and Instagram accounts. Posts were created using flyers and 60-second SJS/TEN survivor video vignettes. Finally, we launched a nationwide Google Ad campaign. To understand the impact of the additional online advertising, we measured the change in registration in both the study interest and the effectiveness of implementation of specific social media and web-based search tools before and after implementation. Results: With the introduction of social media and Google Ads, we report a 48.6% increase in enrollment overall and a 289.5% increase in participation interest. We noticed the ads were accessible to all age groups and notably reported a more even age distribution of enrolled participants from 18 through 74 years, with an average of 15% enrolled in each age category. The largest increase in any age category was seen in the 65- to 74-year-old patients (n=19), with 16.5% of the age distribution. The most significant increase in enrollment and diversity of responses came from Google Ads, with a total of 201 expressions of interest, from 56 enrolled participants, 33% of which self-identified as non-White. VUMC Facebook ads had an enrollment rate of 15.3%, and VUMC Instagram ads saw an enrollment rate of 14.3%. Conclusions: Social media and web-based search tools differ in their enrollment effectiveness. Google Ads were found to be the most effective advertisement for recruitment in this community-based study. Each of the social media and web-based strategies used increased enrollment numbers, accessibility to more age ranges, and diversity of enrollment. They show promise as tools to improve inclusion and enrollment in rare disease research such as SJS/TEN.

Indexed as

AdvertisingInternetSocial MediaStevens-Johnson SyndromeAdultAgedFemaleHumansMaleMiddle AgedUnited StatesYoung Adultaccessibilityadverse drug reactiondiversityGoogle Adsrare diseaserecruitmentSCARsevere cutaneous adverse reactionSJSsocial mediaStevens-Johnson syndromeTENtoxic epidermal necrolysis

Identifiers

PMID40334287
PMCPMC12077847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.